Q1 2024 EPS Estimates for bluebird bio, Inc. (NASDAQ:BLUE) Reduced by Analyst
bluebird bio, Inc. (NASDAQ:BLUE – Free Report) – Analysts at Leerink Partnrs decreased their Q1 2024 earnings per share estimates for shares of bluebird bio in a research report issued on Tuesday, March 26th. Leerink Partnrs analyst M. Foroohar now anticipates that the biotechnology company will post earnings per share of ($0.29) for the quarter, […]
More Stories
White House Says Cuban Regime Is ‘Bound to Fall’
By Travis Gillmore WASHINGTON—White House press secretary Karoline Leavitt addressed the situation in Cuba, where the population of nearly 10...
Fed Still Forecasts Lower Interest Rates This Year Despite Iran Conflict
By Andrew Moran Federal Reserve officials anticipate lower interest rates this year, despite the Iranian conflict clouding the economic outlook,...
Vance to Lead US Delegation to Pakistan for Peace Talks With Iran
By Savannah Hulsey Pointer Vice President JD Vance and a team of negotiators are headed to Pakistan for peace talks...
How the High-Stakes Rescue Mission in Iran Unfolded
By John Haughey President Donald Trump was assured by the Pentagon and Central Intelligence Agency that the assembled array of...
Earnings Season Is About to Begin, and I Expect Positive Changes
By Louis Navellier We’re approaching another earnings season, starting in mid-April, when many of our stocks shine the brightest. Some...
These Detransitioners Sued for Medical Malpractice, but Will They Get Their Day in Court
By Darlene McCormick Sanchez Prisha Mosley thought that she would get her day in court when the North Carolina Legislature...